Corbion reports the progress of its share buyback program 27 October – 31 October 2025 Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 27 October up to and including 31 October 2025 a total of 102.003 shares were repurchased at an average price of €17.6450 for a total amount of €1,799,838.05 To date, the total consideration for shares repurchased amounts to 420,203 shares representing 72.40% of the overall share buyback program. Corbion publishes on a weekly basis every Monday, an overview of the progre...
                                                                                Below are the key highlights from the 3Q results conference call. 3Q top line was a bit weaker than expected whilst 3Q adjusted EBITDA increased by 11% organically and was in line with our and consensus expectations. Corbion still expects organic EBITDA growth of over 25% which translates into c. € 207m when taking into account the expected negative $ effect (KBCS & CSS € 206m). We continue to appreciate Corbion for its market leadership in lactic acid and growth opportunities within the existin...
                                                                                Adyen: 3Q25 results – solid net revenue, FY25 guidance reiterated. Aedifica: Guidance raised, positive tenant trends and good portfolio valuation. Ageas: China Taiping Life 3Q25 Solvency much lower, remains solid. Allfunds Group PLC: Strong flows. ASM International: 3Q25 results - disappointing orders, much better margins. Corbion: Iron wills and nerves of steel. Lotus Bakeries: peer Mondelez 3Q25 results. Melexis: 3Q25 results, ongoing gross margin pressure. Staffing: Dutch figs...
                                                                                3Q top line was a bit weaker than expected whilst 3Q adjusted EBITDA increased by 11% organically and was in line with our and consensus expectations. Corbion still expects organic EBITDA growth of over 25% which translates into c. €207m when taking into account the expected negative $ effect (KBCS & CSS €206m). We continue to appreciate Corbion for its market leadership in lactic acid and growth opportunities within the existing portfolio (food adjacencies, omega-3) whilst looking ahead to the ...
                                            Corbion announces strong YTD EBITDA growth, and EBITDA margin improvement of +240 bps; full-year outlook maintained Corbion Q3 2025 Interim Management Statement Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through application of science, today publishes its results for the first nine months of 2025. Key highlights first nine months 2025: Organic sales growth:+1.2%(Q3: -2.2%) - Volume/mix:+1.7%(Q3: -1.5%) - Price:-0.5%(Q3: -0.7%)Sales€ 957.2 million(Q3: € 311.6 million)Adjusted EBITDA€ 156.3 million(Q3: € 49.7 million)Adju...
                                            Corbion reports the progress of its share buyback program 20 October – 24 October 2025 Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 20 October up to and including 24 October 2025 a total of 22.669 shares were repurchased at an average price of €17.2559 for a total amount of €391,070.36 To date, the total consideration for shares repurchased amounts to 318,200 shares representing 54.83% of the overall share buyback program. Corbion publishes on a weekly basis every Monday, an overview of the progress ...
                                            Corbion reports the progress of its share buyback program 13 October – 17 October 2025 Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 13 October up to and including 17 October 2025 a total of 29.981 shares were repurchased at an average price of €16.6672 for a total amount of €499,698.04 To date, the total consideration for shares repurchased amounts to €5,024,854.16 representing 50.25% of the overall share buyback program. Corbion publishes on a weekly basis every Monday, an overview of the progress o...
                                                                                We keep our HOLD but reduce our target price from €11.5 to €10.5 following Sligro's weak 3Q25 trading update. We continue to view the equity story as a margin recovery play but note that improvements in FY25F are expected to remain modest with the group reiterating its 5.5-6.0% EBITDA margin guidance, while delays in client onboarding in Belgium is another negative, in our view. We therefore reduce our EBIT forecasts by 10% for both FY25F and FY26F. Sligro's balance sheet offers limited room for...
                                            Bonduelle - Statement of availability of 2024-2025 Universal Registration Document BONDUELLE Head office: "La Woestyne" - 59173 Renescure - FranceBonduelle a French S.C.A (Partnership limited by Shares) with a capital of 57 102 699,50 eurosRegistered under number : 447 250 044 ( Dunkerque Commercial and Companies Register) Villeneuve d’Ascq, October 17, 2025 Statement of availability of the 2024-2025 Universal Registration Document The Bonduelle Group announces that its 2024-2025 Universal Registration Document (document d’enregistrement universel) was filed with the Autorité des Mar...
                                            Bonduelle - Mise à disposition du document d'enregistrement universel 2024-2025 BONDUELLE Siège social - "La Woestyne" - 59173 Renescure - FranceBonduelle SCA - Société en commandite par actions au capital de 57 102 699,50 eurosRCS DUNKERQUE 447 250 044 Villeneuve d’Ascq, le 17 octobre 2025 Communiqué de mise à disposition du document d’enregistrement universel 2024-2025 Le Groupe Bonduelle annonce que son document d’enregistrement universel 2024-2025 a été déposé auprès de l’Autorité des marchés financiers (AMF), le 16 octobre 2025. Ce document est tenu à la disposition du public d...
    
            Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.